0001716947 2026-06-04 2026-06-04 0001716947 1 2026-06-04 2026-06-04 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001716947 Ensysce Biosciences, Inc. N/A N/A S-3 Ensysce Biosciences, Inc. false Equity Common Stock, par value $0.0001 per share ("Common Stock") true 1300000 0.2977 387010.00 0.0001381 53.45 387010.00 53.45 0.00 0.00 53.45 The shares of the Registrant's common stock, par value $0.0001 per share (the "Common Stock"), offered hereby also include such presently indeterminate number of shares of Common Stock as a result of stock splits, stock dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee at a fee rate of 0.00013810 ($138.10 per $1 million), the proposed maximum offering price per share is $0.2977, which is the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on May 28, 2026, which date is within five business days prior to filing this Registration Statement. Represents an aggregate of 1,300,000 shares of common stock registered for sale by the selling stockholders named in this registration statement (after giving effect to certain potential anti-dilution and other adjustments).